Athersys Inc. Stock
Your prediction
Athersys Inc. Stock
Our community identified positive and negative aspects for Athersys Inc. stock for the coming years. 2 users see the criterium "Worthwhile Investment for the next years" as a plus for the Athersys Inc. stock. On the other hand our users think that "Unique positioning" could be a problem in the future.
Pros and Cons of Athersys Inc. in the next few years
Pros
?
M***** P*******
?
S********** s********
?
C******** o* t** e**********
Cons
?
B****
?
G***** c******* t* c**********
?
W********* I********* f** t** n*** y****
Tell us your opinion to access the 'Wisdom of the Crowds'
Performance of Athersys Inc. vs. its peers
| Security | Change(%) | 1w | 1m | 1y | YTD | 3y | 5y |
|---|---|---|---|---|---|---|---|
| Athersys Inc. | - | - | - | - | - | - | - |
| Evolus Inc | -0.040% | -0.954% | -14.526% | -33.462% | -4.771% | -42.967% | -41.356% |
| Heron Therapeutics Inc. | 1.530% | 3.155% | 15.773% | -72.386% | -61.257% | -69.171% | -95.838% |
| Rhythm Pharmaceuticals | -1.080% | 1.667% | -5.181% | 26.207% | -2.139% | 479.114% | 535.417% |
Comments
Athersys, Inc. (NASDAQ: ATHX) is now covered by analysts at Alliance Global Partners. They set a "buy" rating on the stock.
Show more
Ratings data for ATHX provided by MarketBeat
